Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novartis AG Common Stock
(NY:
NVS
)
146.03
+0.64 (+0.44%)
Official Closing Price
Updated: 7:00 PM EDT, May 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,067,501
Open
146.45
Bid (Size)
144.75 (100)
Ask (Size)
148.17 (100)
Prev. Close
145.39
Today's Range
145.48 - 146.67
52wk Range
104.93 - 170.46
Shares Outstanding
N/A
Dividend Yield
3.27%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
BioAge Labs R&D Day: BGE-102 Phase I Shows Big hs-CRP Drops, Sets Up Cardio & DME POC Trials
↗
May 08, 2026
BioAge Labs (NASDAQ:BIOA) used its R&D Day event to provide an update on its lead program, BGE-102, an oral, brain-penetrant inhibitor of the NLRP3 inflammasome that the company is developing across...
Via
MarketBeat
PTCT Q1 2026 Earnings Transcript
↗
May 08, 2026
PTCT Q1 2026 Earnings Transcript
Via
The Motley Fool
Performance
YTD
+5.4%
+5.4%
1 Month
-5.4%
-5.4%
3 Month
-6.6%
-6.6%
6 Month
+15.6%
+15.6%
1 Year
+32.6%
+32.6%
More News
Read More
This Small Biotech — Taking On AbbVie, Novartis And Sanofi — Just Catapulted Into A Breakout
↗
May 06, 2026
Via
Investor's Business Daily
Novartis AG-Sponsored ADR (NYSE:NVS) Presents a Compelling Case for Dividend Investors
↗
April 08, 2026
Via
Chartmill
Incyte (INCY) Q2 2025 Earnings Transcript
↗
April 28, 2026
Via
The Motley Fool
Novartis Dips As Generics Take A Bite Out Of Its First-Quarter Sales
↗
April 28, 2026
Via
Investor's Business Daily
Better Pharma Dividend Stock: Novartis vs. Merck
↗
April 17, 2026
Via
The Motley Fool
Topics
Intellectual Property
J&J Shatters Estimates as Oncology and MedTech Power 2026 Outlook Higher
April 15, 2026
Via
MarketMinute
Topics
Economy
Intellectual Property
MedTech Surge and Oncology Resilience Drive Johnson & Johnson to Q1 Earnings Beat
April 14, 2026
Via
MarketMinute
Topics
Bankruptcy
Earnings
Economy
Big Pharma Deepens AI Ties. What It Means For Novo, Novartis.
↗
April 14, 2026
Via
Investor's Business Daily
Topics
Artificial Intelligence
The Radiopharmaceutical Renaissance: A Deep Dive into Telix Pharmaceuticals (TLX)
April 13, 2026
Via
Finterra
Topics
Economy
Initial Public Offering
3 Low-Volatility ETFs for Peace of Mind in Turbulent Times
↗
April 13, 2026
Via
MarketBeat
Topics
ETFs
The "Liberation Day" Shockwave: US Finalizes 100% Tariffs on Branded Pharmaceutical Imports
April 06, 2026
Via
MarketMinute
Topics
Economy
World Trade
Trump Issues Landmark Executive Order: 100% Tariffs on Imported Patented Drugs to Force Onshoring
April 03, 2026
Via
MarketMinute
Topics
Economy
Government
Lawsuit
Legend Biotech (LEGN) Q4 2024 Earnings Transcript
↗
April 01, 2026
Via
The Motley Fool
Topics
Earnings
Economy
World Trade
Legend Biotech (LEGN) Q1 2025 Earnings Transcript
↗
April 01, 2026
Via
The Motley Fool
Biogen's $5.6 Billion Acquisition of Apellis: A Strategic Pivot into Rare Kidney Diseases
March 31, 2026
Via
MarketMinute
Could Investing $10,000 in VYMI Make You a Millionaire?
↗
March 30, 2026
Via
The Motley Fool
Topics
ETFs
Stocks
Novartis Bets $2 Billion To Deepen Allergy Drug Pipeline
↗
March 27, 2026
Via
Benzinga
International ETFs: EEM and IEFA Offer Distinct Global ETF Choices
↗
March 27, 2026
Via
The Motley Fool
Topics
ETFs
Sarepta Therapeutics (SRPT) Stock Surges 34.98% on Breakthrough Clinical Data
March 26, 2026
Via
MarketMinute
The Second Act: A Deep-Dive into Corcept Therapeutics and the FDA Approval of Lifyorli
March 26, 2026
Via
Finterra
Topics
Economy
Intellectual Property
The $6.7 Billion Pivot: A Deep Dive into Terns Pharmaceuticals (TERN) and the Merck Acquisition
March 25, 2026
Via
Finterra
Topics
Initial Public Offering
Intellectual Property
World Trade
Retirees: Collect a High Dividend While Diversifying Your Portfolio With This ETF
↗
March 24, 2026
Via
The Motley Fool
Topics
ETFs
Retirement
3 ETFs Built for the Volatile Market We're Seeing in March 2026
↗
March 22, 2026
Via
The Motley Fool
Topics
ETFs
Economy
Stocks
Frequently Asked Questions
Is Novartis AG Common Stock publicly traded?
Yes, Novartis AG Common Stock is publicly traded.
What exchange does Novartis AG Common Stock trade on?
Novartis AG Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novartis AG Common Stock?
The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange
What is the current price of Novartis AG Common Stock?
The current price of Novartis AG Common Stock is 146.03
When was Novartis AG Common Stock last traded?
The last trade of Novartis AG Common Stock was at 05/08/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
